# Early Initiation of Tumor Necrosis Factor Antagonist–Based Therapy for Patients With Crohn’s Disease Reduces Costs Compared With Late Initiation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/early-initiation-of-tumor-necrosis-factor-antagonist-based-therapy-for-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Candace L. Beilman,Erin Kirwin,Christopher Ma,Christopher McCabe,Richard N. Fedorak,Brendan P. Halloran |
| Citations | 21 |
| DOI | 10.1016/j.cgh.2018.07.032 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2884536837 |
| PMID | 30056180 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Erin Kirwin](https://scholariq.org/researchers/erin-kirwin/)

## Paper journal

- [Clinical Gastroenterology and Hepatology](https://scholariq.org/journals/clinical-gastroenterology-and-hepatology/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.